MCL1 and acute myeloid leukemia: Apoptosis-related processes have been reported to be significant in AML, connecting the BAX/BCL2 ratio with the clinical outcome of patients with de novo AML, and elevated MCL1 expression with AML relapses [8], [46], [47].